Tadros R, Billette J. Rate-dependent AV nodal refractoriness: a new functional framework based on concurrent effects of basic and pretest cycle length. Am J Physiol Heart Circ Physiol 297: H2136-H2143, 2009. First published October 9, 2009 doi:10.1152/ajpheart.00712.2009.-The atrioventricular (AV) node filters atrial impulses. Underlying rate-dependent refractory properties are assessed with the effective (ERPN; longest nonconducted atrial cycle length) and functional (FRPN; shortest His bundle cycle) refractory period determined with premature protocols at different basic rates. Fast rates prolong ERPN and shorten FRPN, but these effects vary with subjects, age, and species. We propose that these opposite and variable effects reflect the net sum of concurrent cumulative and noncumulative effects associated with basic (BCL) and pretest cycle length (PTCL), respectively. To test this hypothesis, we assessed selective and combined effects of five BCL (S1S1) and six PTCL (S1S2) on ERPN, FRPN, and their subintervals (ERPN ϭ A2H2 ϩ H2A3 and FRPN ϭ H2A3 ϩ A3H3, where A is atrium and H is His bundle) with S 1S2S3 protocols in six rabbit heart preparations. At control BCL, PTCL shortenings prolonged ERPN (113 Ϯ 12 vs. 101 Ϯ 14 ms, P Ͻ 0.01) as a net result of prolonged A2H2 and curtailed H2A3. At control PTCL, BCL shortenings increased ERPN (127 Ϯ 20 vs. 101 Ϯ 14 ms, P Ͻ 0.01) by prolonging A 2H2. FRPN did not vary with BCL but decreased (163 Ϯ 6 vs. 175 Ϯ 10 ms, P Ͻ 0.01) with PTCL that curtailed H2A3. Equal BCL and PTCL shortenings as in standard protocols prolonged ERPN but left FRPN unchanged. Notably, ERPN and FRPN significantly correlated through their H 2A3 subinterval. In conclusion, BCL and PTCL are both important determinants of AV nodal refractoriness and together account for rate-induced changes in ERPN and FRPN observed during standard premature protocols. ERPN and FRPN are related variables. Similar functional rules may govern nodal refractory behavior during supraventricular tachyarrhythmias. atrioventricular node; heart rate; effective refractory period; functional refractory period; rate dependence THE ATRIOVENTRICULAR (AV) node generates a delay between atrial and ventricular activation and filters atrial impulses during tachyarrhythmias. Hence, optimal filtering of atrial impulses through pharmacological modulation of AV nodal function has become a cornerstone of atrial fibrillation therapy (22). Underlying intrinsic rate-dependent AV nodal refractory properties are commonly assessed in clinical or drug studies with the effective (ERPN) and functional (FRPN) refractory period determined with premature protocols performed at different basic rates (12, 18, 19, 24, 32, 34) . However, resulting data remain puzzling in several respects. First, and for as-yet unclear reasons, ERPN increases with rate (11, 12, 27, 36), 16, 17, 24) . Second, these effects vary much with subjects, age, and species and often depart from the main trend (7, 8, 12, 13, 26, 35, 38) . Third, a fast rate induces both cumulative and noncumulative effects on nodal function, but their relative contribution to nodal responses occurring during standard premature protocols cannot be currently sorted out (6, 8, 17, 24, 29, 39) . Finally, ERPN and FRPN are composed of atrial-His and His-atrial subintervals that vary differently with rate (8, 10, 16, 38) . We assessed the hypothesis that this imbroglio reflects the plural nature of rate effects on AV nodal refractoriness. Specifically, we propose that cumulative effects of basic cycle length (BCL) and noncumulative effects of pretest cycle length (PTCL) constitute independent determinants of rate-induced changes in ERPN and FRPN, including those arising from standard protocols. To sort out these effects, we independently varied BCL and PTCL with S 1 S 2 S 3 protocols. In this manner, we could determine selective BCL, selective PTCL, and combined BCL and PTCL effects on ERPN, FRPN, and their subintervals. The data support a new framework of intrinsic functional rules governing rate-dependent AV nodal refractory behavior.
atrioventricular node; heart rate; effective refractory period; functional refractory period; rate dependence THE ATRIOVENTRICULAR (AV) node generates a delay between atrial and ventricular activation and filters atrial impulses during tachyarrhythmias. Hence, optimal filtering of atrial impulses through pharmacological modulation of AV nodal function has become a cornerstone of atrial fibrillation therapy (22) . Underlying intrinsic rate-dependent AV nodal refractory properties are commonly assessed in clinical or drug studies with the effective (ERPN) and functional (FRPN) refractory period determined with premature protocols performed at different basic rates (12, 18, 19, 24, 32, 34) . However, resulting data remain puzzling in several respects. First, and for as-yet unclear reasons, ERPN increases with rate (11, 12, 27, 36) , whereas FRPN decreases (10 -12, 16, 17, 24) . Second, these effects vary much with subjects, age, and species and often depart from the main trend (7, 8, 12, 13, 26, 35, 38) . Third, a fast rate induces both cumulative and noncumulative effects on nodal function, but their relative contribution to nodal responses occurring during standard premature protocols cannot be currently sorted out (6, 8, 17, 24, 29, 39) . Finally, ERPN and FRPN are composed of atrial-His and His-atrial subintervals that vary differently with rate (8, 10, 16, 38) . We assessed the hypothesis that this imbroglio reflects the plural nature of rate effects on AV nodal refractoriness. Specifically, we propose that cumulative effects of basic cycle length (BCL) and noncumulative effects of pretest cycle length (PTCL) constitute independent determinants of rate-induced changes in ERPN and FRPN, including those arising from standard protocols. To sort out these effects, we independently varied BCL and PTCL with S 1 S 2 S 3 protocols. In this manner, we could determine selective BCL, selective PTCL, and combined BCL and PTCL effects on ERPN, FRPN, and their subintervals. The data support a new framework of intrinsic functional rules governing rate-dependent AV nodal refractory behavior.
MATERIALS AND METHODS
Data were obtained from six isolated, superfused rabbit heart preparations in conformity with the American Physiological Society's guiding principles in the care and use of animals. Experimental procedures were reviewed and approved by the Institutional (Université de Montréal) Animal Care and Use Committee. The experiments correspond to those described in two previous studies on AV nodal conduction in which we used S 1S2S3 stimulation protocols to independently vary basic (BCL; S 1S1), pretest (PTCL; S1S2), and test cycle length (TCL; S 2S3) (Fig. 1A) (30, 31) . Short BCL induces cumulative effects that impair nodal function. Because of their long time constant (9, 31) , these cumulative BCL effects are not altered by PTCL (6, 30) . The independence of BCL and PTCL effects on AV nodal refractory properties was confirmed by the absence of statistically significant interaction between them. For any given S 1S2S3 protocol, nodal responses to TCL scanning (Fig. 1B) were used to determine ERPN and FRPN as well as to construct a refractory curve (H 2H3 vs. A2A3) that was displayed in reference to an identity line (Fig. 1C) . The refractory curve allowed tracking overall changes in nodal responses in addition to those affecting ERPN and FRPN.
The effects of 5 BCL (S 1S1: control and 25, 50, 75, and 100% shortening) and 6 PTCL (S 1S2: control and 25, 50, 75, 100, and 125% shortening) were tested in 30 combinations. In this manner, we assessed the effects of BCL shortenings occurring at fixed PTCL and vice versa, as well as the effects of equal BCL and PTCL shortenings that reproduced beat sequences equivalent to those occurring during standard premature protocols performed at different basic rates. In nodal responses to S 1S2S3 protocols, subscripts 1, 2, and 3 mark the basic, pretest, and test beat events, respectively (Fig. 1A) . A and H stand for atrial and His bundle activation, respectively. The control BCL was given by spontaneous atrial cycle length minus 30 ms. The shortest BCL studied (100% shortening) corresponds to the shortest cycle length resulting in steady-state 1:1 nodal conduction during 5 min, established by trial and error, and to which a 20-ms safety margin value was added to prevent the occurrence of blocked beats. As listed above, the resulting BCL range was divided into quartiles. This division also applies to PTCL, yet PTCL shorter than the shortest BCL resulted in conducted beats. A 125% PTCL shortening was regularly tested and thus included in analyses. Cycle lengths (means Ϯ SD) were as follows: control (367 Ϯ 37 ms) and shortenings of 25% (325 Ϯ 27 ms), 50% (283 Ϯ 18 ms), 75% (242 Ϯ 11 ms), 100% (200 Ϯ 13 ms), and 125% (159 Ϯ 20 ms). Basic trains contained 15 S 1 beats. Premature beat testing was started 5 min after any change in BCL, i.e., at steady state (9, 30, 31) . Precision of interval measurement was Ͻ0.5 ms.
In data from S 1S2S3 protocols, ERPN corresponds to the longest blocked A2A3. When atrial block occurred before nodal block (9/180 measurements), ERPN was estimated by the shortest conducted A2A3. FRPN corresponds to the shortest H2H3. ERPN (A2H2 ϩ H2A3) and FRPN (H2A3 ϩ A3H3) subintervals were systematically determined. A noncumulative effect is one that develops after a single cycle of a fast rate and remains unchanged in subsequent constant cycles. A cumulative effect is one that is virtually absent after a single short cycle and develops with time during the fast rate. BCL and PTCL effects on ERPN, FRPN, and their subintervals were assessed with ANOVA for repeated measurement studies (SPSS for Windows). Data are means Ϯ SD. Stability over the experimental time has already been documented (30) . The term "AV node" is meant to include all structures contributing to the nodal recovery curve (5, 14) .
RESULTS

Effects of Basic and Pretest Cycle Length on the AV Nodal Refractory Curve
Selective PTCL shortenings. Nodal refractory curves obtained from one preparation at five PTCL values but constant 420-ms BCL (control), i.e., in the absence of cumulative effects, are shown in Fig. 2A . Shortenings of PTCL from 420 (control) to 145 ms (125% shortening) increasingly shifted the refractory curve away from the control curve and identity line in the long A 2 A 3 range. At short A 2 A 3 , the refractory curve was shifted rightward and downward from control curve, leading to increased ERPN and shortened FRPN, respectively. Notably, PTCL affects all data points of the refractory curve.
Selective BCL shortenings. Graded BCL shortenings from 420 (control) to 200 ms (100% shortening) tested at constant 420-ms PTCL, i.e., in the absence of PTCL effects, yielded refractory curves that overlapped with the control curve and identity line over the long A 2 A 3 range (Fig. 2B ). This apparent absence of effects was the net result of nearly equal A 2 H 2 and A 3 H 3 prolongations that shifted the refractory curve rightward and upward along the identity line. At short A 2 A 3 , BCL shortenings mainly tilted the refractory curve rightward. This tilting led to prolonged ERPN, whereas FRPN remained virtually unchanged.
Combined BCL and PTCL shortenings. Different BCL and PTCL combinations affected the refractory curve in different manners. Globally, combined effects reflected the sum of those observed when corresponding BCL and PTCL were separately tested. Figure 2C shows refractory curves obtained for the special case of equal BCL and PTCL shortenings, as in standard premature protocols. Equal 420 (control)-, 310-, 255-, and 200-ms BCL-PTCL values shifted the right portion of the refractory curve away from the control curve and identity line (Fig. 2C) , as did PTCL shortenings. In the short A 2 A 3 range, the curves were shifted rightward. This shift increased ERPN, as did both selective BCL and PTCL shortenings. FRPN decreased slightly in this preparation, but this effect was inconsistent among preparations. These data show that combined BCL and PTCL shortenings affect the refractory curve in a manner that reflects the net sum of their individual effects.
Effects of Basic and Pretest Cycle Length on ERPN, FRPN, and Their Subintervals
ERPN and subintervals. Typical changes in ERPN and its subintervals from one preparation are shown with ladder diagrams in Fig. 3 . A 2 A 3 , A 2 H 2 and H 2 A 3 corresponding to ERPN obtained at control (Fig. 3A) and under a 200-ms PTCL (Fig.  3B ), a 200-ms BCL (Fig. 3C) , and equal 200-ms BCL-PTCL shortenings (Fig. 3D ) are displayed. The PTCL shortening prolonged A 2 H 2 from 68 to 84 ms but shortened H 2 A 3 from 38 to 34 ms for a net 12-ms prolongation of ERPN (Fig. 3B) . The selective BCL shortening prolonged A 2 H 2 to 94 ms and H 2 A 3 to 44 ms for a net 32-ms increase in ERPN (Fig. 3C ). The equal BCL-PTCL shortening further prolonged A 2 H 2 to 115 ms but shortened H 2 A 3 to 33 ms for a net 42-ms increase in ERPN (Fig. 3D) .
On average, ERPN increased from 101 Ϯ 14 to 113 Ϯ 12 ms (P Ͻ 0.01) between control and the shortest PTCL tested at control BCL (Fig. 4A and Table 1 ). This ERPN increase was associated with an increased A 2 H 2 (62 Ϯ 4 to 90 Ϯ 15 ms, P Ͻ 0.01) and reduced H 2 A 3 (39 Ϯ 14 to 24 Ϯ 21 ms, P Ͻ 0.01) (Fig. 4 , B and C, and Table 1 ). Statistically significant changes in ERPN and its subintervals also were observed when the same PTCL shortenings were tested at different constant BCL (Fig. 4 , A-C, and Table 1 ). Thus PTCL shortenings increase ERPN at all BCL as a net result of opposite changes in its subintervals.
BCL shortenings tested at the control PTCL value increased ERPN from 101 Ϯ 14 to 127 Ϯ 20 ms (P Ͻ 0.01) ( Fig. 4A and Table 1 ). This BCL-induced increase in ERPN primarily involved its A 2 H 2 subinterval, which increased from 62 Ϯ 4 to 74 Ϯ 10 ms (P Ͻ 0.01) (Fig. 4B and Table 1 ). Similar BCL effects on ERPN and A 2 H 2 were observed for all constant PTCL tested. BCL shortenings also increased H 2 A 3 at ERPN, but this effect failed to reach statistical significance (Fig. 4C) . Thus BCL shortenings prolong ERPN at all PTCL primarily by increasing A 2 H 2 .
Combined BCL-PTCL shortenings increased ERPN in a manner predictable from the sum of selective BCL and PTCL effects ( Fig. 4A and Table 1 ). This additive nature and independence of combined BCL and PTCL effects was further supported by the absence of statistically significant interaction between them in all studied variables.
Equal BCL-PTCL shortenings, as in standard premature protocols, increased ERPN from 101 Ϯ 14 to 134 Ϯ 25 ms at maximum shortening (P Ͻ 0.01) (dotted line in Fig. 4A and Table 1 ). Notably, this 33-ms ERPN prolongation closely approximated the 31-ms sum that arose from a 12-ms PTCLinduced A 2 H 2 increase, 12-ms BCL-induced A 2 H 2 increase, 7-ms PTCL-induced H 2 A 3 decrease, and 14-ms BCL-induced H 2 A 3 increase (Table 1) even though only the first three effects were statistically significant. Thus BCL and PTCL effects on ERPN occurring during standard protocols are additive and involve at least three distinct effects.
FRPN and subintervals. FRPN decreased with PTCL. The shortest PTCL tested at control BCL decreased FRPN from 175 Ϯ 10 to 163 Ϯ 6 ms (P Ͻ 0.01) (Fig. 5A and Table 1 ). This decrease became statistically significant starting from the 75% PTCL shortening, was associated with an H 2 A 3 shortening from 68 Ϯ 9 to 53 Ϯ 14 ms (P Ͻ 0.01) (Fig. 5B) , and occurred without statistically significant changes in the A 3 H 3 subinterval (Fig. 5C and Table 1 ). Similar PTCL-induced decreases in FRPN and H 2 A 3 were observed at different BCL ( Fig. 5 and Table 1 ). Thus noncumulative effects of PTCL shortenings curtailed FRPN at all BCL, primarily by shortening its H 2 A 3 subinterval.
FRPN slightly increased from 175 Ϯ 10 to 183 Ϯ 17 ms under the shortest BCL tested at a constant control PTCL, but this effect did not reach statistical significance (Fig. 5A and Table 1 ). Similar observations were made at all tested PTCL. BCL shortenings did not significantly alter FRPN subintervals either, at any PTCL (Fig. 5, B and C, and Table 1 ). Equal BCL-PTCL shortenings also did not alter FRPN or its subintervals ( Fig. 5 and Table 1 ). Globally, FRPN decreased with PTCL but was insensitive to BCL.
Relationship Between ERPN and FRPN
The above-described findings show that ERPN increases and FRPN decreases with decreasing PTCL. Decreasing BCL val- 79Ϯ10  42Ϯ17  175Ϯ12  62Ϯ16  113Ϯ19  75  100  123Ϯ14  87Ϯ14  36Ϯ20  172Ϯ11  56Ϯ18  116Ϯ20  75  125  130Ϯ17  104Ϯ23  26Ϯ24  164Ϯ12  43Ϯ24  122Ϯ22   100  Control  127Ϯ20  74Ϯ10  53Ϯ22  183Ϯ17  69Ϯ19  113Ϯ20  100  25  127Ϯ21  77Ϯ11  51Ϯ23  182Ϯ17  69Ϯ17  113Ϯ20  100  50  129Ϯ24  80Ϯ11  49Ϯ26  182Ϯ17  66Ϯ18  116Ϯ20  100  75  130Ϯ25  85Ϯ13  45Ϯ27  178Ϯ17  60Ϯ25  118Ϯ24  100  100  134Ϯ25  96Ϯ19  39Ϯ29  174Ϯ16  54Ϯ28  120Ϯ25  100  125  145Ϯ28  113Ϯ31  32Ϯ32  169Ϯ17  53Ϯ30  116Ϯ24 Values are means Ϯ SD; n ϭ 6. BCL and PTCL, basic and pretest cycle length expressed as control or a percentage of cycle length shortening. Bold type indicates identical BCL and PTCL values, as in standard premature protocols. Supplemental Table 1 (Fig. 6B ) in all preparations. The individual r of positive relationships ranged between 0.50 and 0.98 and were all significant (P Ͻ 0.01). Because A 3 H 3 at FRPN did not vary significantly and because H 2 A 3 at ERPN and FRPN was insensitive to BCL, the ERPN-FRPN relationship mainly depended on PTCL-induced H 2 A 3 shortenings affecting both ERPN and FRPN (Figs. 4C and 5B). These data support a new H 2 A 3 -based relationship between ERPN and FRPN.
DISCUSSION
Main Findings
Our study has revealed several new features of intrinsic functional rules that govern the AV nodal rate-dependent refractory properties. Data show that BCL and PTCL modulate these properties in an independent but additive manner. Combined BCL-PTCL variations, as in standard protocols, result in changes in ERPN, FRPN, and their subintervals that correspond to the sum of those induced when the same BCL and PTCL were selectively tested. Specifically, ERPN prolongations observed with standard protocols were shown to result from three significant effects: A 2 H 2 prolongations arising from PTCL and BCL shortenings concurring with a PTCL-induced H 2 A 3 shortening (Figs. 3 and 4 and Table 1 ). BCL did not affect FRPN, whereas PTCL shortenings curtailed it through changes in H 2 A 3 (Fig. 5, A and B) . Importantly, our data show that rate-induced changes in ERPN and FRPN correlate through parallel PTCL-induced shortenings in H 2 A 3 , a relation masked by A 2 H 2 changes affecting ERPN (Fig. 6) .
Relations to Previous Studies on Rate-Dependent AV Nodal Refractoriness
Refractory curve. Increasing basic rates during standard premature protocols increasingly shifts the right portion of the refractory curve below the control curve and identity line and shifts the left portion rightward (Fig. 2C) . Because they are variable and of unclear significance (16, 26) , these shifts are often simply ignored. Our study shows that PTCL and BCL shortenings shifted the refractory curve away and along the identity line, respectively (Fig. 2, A and B) . Combined BCL and PTCL shortenings altered for the same data. The relationship was statistically significant in all preparations (P Ͻ 0.01). In A and B, different symbols correspond to data from different preparations (Prep 1-6) , and each data point corresponds to one of 30 S1S2S3 protocols. the refractory curve in both manners (Fig. 2C) . We thus established the distinct effects of PTCL and BCL shortenings on the AV nodal refractory curve and their respective role in changes observed during standard premature protocols.
ERPN. ERPN increases with basic rate, an effect typically attributed to a cumulative prolongation of nodal refractoriness (10 -12, 15, 18, 19, 23, 24, 27, 28, 36) . However, some substantial ERPN prolongations occurred after a single short cycle and thus ought to be noncumulative (29, 36) . Interestingly, many studies include cases of unchanged and even shortened ERPN. Moreover, rate-induced ERPN shortenings are consistently observed in young children (13, 38) and dogs (7, 26, (33) (34) (35) . These observations suggest that rate-induced ERPN prolongations involve both cumulative and noncumulative effects and may hide a shortening factor. The use of S 1 S 2 S 3 protocols allowed us to sort out these effects for different BCL-PTCL combinations, including those corresponding to standard protocols, as summarized above. The finding that rate-induced ERPN prolongations reflect the net sum of concurrent and partly opposite effects may explain that these prolongations are highly variable and sensitive to factors such as subjects, species, and age (7, 12, 13, 20, 26, 35, 38) .
FRPN. Small and inconsistent rate-induced FRPN shortenings are observed with standard protocols (1-3, 7, 8, 10 -13, 16, 17, 24, 26, 27, 34 -36, 39) . Because similar FRPN shortenings develop after a single short cycle and dissipate after a single long cycle, they are definitively noncumulative (3, 8) . The present study confirms an earlier one (8) that showed an FRPN decrease with PTCL that curtails H 2 A 3 (Fig. 5) . Because FRPN did not significantly vary with BCL, we expected but did not observe a net FRPN shortening under equal BCL-PTCL shortenings, as reported for standard protocols. This diverging result may be related to the fact that our measurements were carried out at steady state (5 min of fast rate), an approach rarely used by others. Although BCL effects on FRPN did not reach statistical significance in the present study (Fig. 5A) , they may have been sufficient to interfere with PTCL-induced H 2 A 3 shortening.
ERPN, FRPN, and AV Nodal Excitability Cycle
The exact significance of BCL-and PTCL-induced changes in ERPN and FRPN in terms of nodal cell excitability remains to be determined. A classic study has established, with field stimulation and action potential recordings, that in most typical nodal (N) cells, recovery of excitability is slow and progressive and lags beyond repolarization (25) . The same study also showed that activation delay of N cells is sensitive to rate. These observations were interpreted as evidence that N cells play a key role in rate-dependent AV nodal refractory and recovery properties. However, transmembrane action potentials directly recorded during premature protocols showed that, at a control slow basic rate, ERPN and FRPN values relate to the minimum interval between action potential upstrokes in proximal and distal nodal cells, respectively, but not in N cells (4) . This interval estimates the time during which a given cell is refractory to a propagating activation wave front. The typical instability of nodal cell impalements prevents the determination of this variable during lasting fast rates.
Notwithstanding the limited data available on the intranodal origin of rate-induced changes in ERPN and FRPN, we suggest that BCL and PTCL may alter the nodal excitability cycle in three manners. First, the excitability cycle may be delayed in reference to the A 2 beat. A prolonged A 2 H 2 is deemed to postpone the beginning of activation and hence recovery in AV nodal cells in reference to A 2 , especially in cells located farther in nodal delay. Therefore, the A 3 beat ending a constant A 2 A 3 unavoidably occurs at an earlier phase of nodal cell recovery after an increased A 2 H 2 . Such a deferred excitability cycle of nodal cells may contribute to A 2 H 2 -related ERPN prolongations (Fig. 4B) . Second, shortened action potential duration also may be involved. Consistent with that possibility, we have reported a 40-ms reduction of action potential duration in distal nodal cells after a single short cycle (4) . Shorter action potential duration favors an earlier nodal recovery of excitability in reference to A 2 (15) . This may explain why H 2 A 3 at both ERPN and FRPN were shortened under PTCL effects (Figs. 4C and 5B). Third, a short BCL may decrease excitability throughout the recovery cycle (25) . Combined BCL-PTCL effects likely involve all three mechanisms.
Role of His-Atrial Interval in AV Nodal Refractory Properties
Our data show that PTCL shortenings curtail H 2 A 3 , an effect that shortens both ERPN and FRPN (Figs. 4C and 5B) and accounts for the relationship between FRPN and ERPN Ϫ ⌬A 2 H 2 (Fig. 6B) . Interestingly, a similar dependence of rateinduced decreases in FRPN on ventriculoatrial interval has been observed in humans (10 4C and 5B) also remain unclear. Further studies are necessary to answer these questions as well as to establish the role of conduction in nodal refractoriness.
Implications
The observation that BCL and PTCL shortenings induce independent, concurrent, and partly opposite effects on ERPN, FRPN, and their subintervals compels the consideration of these effects in any assessment of rate-dependent AV nodal refractory properties. For instance, our data support an approach to measure cumulative BCL effects on ERPN directly without interference from PTCL-like effects. BCL effects are often a target due to their involvement in lasting supraventricular tachyarrhythmias. Our data indicate that cumulative BCL effects can be directly measured by varying BCL in the presence of a constant long PTCL. The long cycle introduced between the last basic cycle and test cycle dissipates the noncumulative PTCL-like effects present at the last beat of the fast rate and prevents its interference with cumulative BCL effects at the test beat. The relevant BCL zone can then be explored with a small number of protocols. Similarly, when PTCL effects constitute the target of a study, one may take advantage of the facts that they do not vary with BCL and become significant with 75% PTCL shortenings to reduce the number of protocols needed to explore them. These PTCL effects should, among other benefits, help predict nodal behavior at the onset of tachyarrhythmias and during irregular rhythms. The above approaches also may be adapted to char-acterize AV nodal effects of pharmacological agents such as those used for rate-control therapy during atrial fibrillation. Thus, although our complete profile of BCL and PTCL effects was established with 30 S 1 S 2 S 3 protocols, a study may well explore specific portions of this profile with fewer protocols.
The important role of changes in pretest nodal conduction time in ERPN measurements has been previously recognized (37, 39) . This factor has been accounted for by subtracting the increase in conduction time from ERPN prolongations observed in response to increased basic rates during standard protocols. This approach eliminates the contribution of the conduction factor from ERPN measurements and thus can be used for this purpose. However, this approach fails to sort out cumulative from noncumulative effects on pretest conduction time and their respective contribution to ERPN prolongation. Only the S 1 S 2 S 3 protocols with subinterval analyses allows us to do that.
Limitations
The sample size was small (n ϭ 6). It is possible that a larger sample size could have allowed, for instance, BCL effects on FRPN and H 2 A 3 to reach statistical significance. Another limitation arises from the fact that the cellular counterpart of BCL-PTCL-induced changes in ERPN, FRPN, and their subintervals remains to be factually established. The roles of AV nodal cell types, dual pathway physiology, and complex architecture in overall nodal refractory properties as characterized with S 1 S 2 S 3 protocols also remains to be determined. However, the documented framework provides a comprehensive basis from which to probe cellular mechanisms underlying rate-dependent AV nodal refractoriness.
Conclusions
Cumulative BCL and noncumulative PTCL effects are concurrent additive determinants of rate-induced changes in AV nodal refractoriness. Rate-induced increases in ERPN observed with standard premature protocols arise from three concurrent and partly opposite BCL and PTCL effects. FRPN decreases with PTCL but is largely insensitive to BCL. Thus both ERPN and FRPN can change on a beat-to-beat basis, but only ERPN can change on a longer time scale. Finally, rate-induced variations in ERPN and FRPN are interrelated through parallel changes in their His-atrial subinterval. Together, our data support a new framework of functional rules governing ratedependent AV nodal refractoriness. This framework may apply to nodal behavior during supraventricular tachyarrhythmias and provides a comprehensive basis to probe and establish underlying cellular mechanisms.
